Pfizer, a major pharmaceutical company, recently witnessed a substantial fall in its third-quarter sales. The primary reason was a drop in COVID-19 vaccine sales, as well as other related products, resulting in a massive loss of $2.4 billion. Compared to previous years, when the company enjoyed a large profit of $8.6 billion, this fall is substantial. Even though the company foresaw these obstacles and amended their plans, sales toppled by a staggering 42%; yet, Pfizer isn't losing hope. They are looking towards their long-term projects, and count on their resources to pull through in sustainable ways.
globalEDGE Blog - By Tag: global-healthcare-series
Publish Date:
Sleeping is known to be one of the most essential aspects in our lives; yet, many people overlook it. The Centers for Disease Control and Prevention states that more than one in three adults in the U.S. are sleep-deprived, leading to many concerning factors that can affect individuals' health.
Publish Date:
Given the myriad of groundbreaking new biotechnology products coupled with accelerating costs of research, development, manufacturing, and regulatory mandates, the healthcare industry today finds itself at a crossroads. Consumers, hospitals, and governments are petitioning for fairly priced goods and services without compromising top-tier quality or extending risk exposure. However, the narrowing global economic environment is persuading market-leading manufactures to reevaluate not only their value chain processing, but also their premium pricing models. Under the aforementioned conditions, it is often in the best interest of suppliers, consumers, and shareholders to empower profit maximization by outsourcing core operational services for efficiency.
Publish Date:
What is something that we have we learned from medical epidemics? Globalization is a gift and a curse. As the world continues to unite and globalize goods, services, and cultures, there is one element that is still lagging behind - the globalization of healthcare. With globalization, traveling has never been easier as you can go from and to any part of the world in 24 hours. On top of that, growing cooperation between countries has decreased the alertness on country borders. Ultimately, this has become one of the causes of the global spread of diseases and infections, since they can spread at a rapid and dismantling pace. Attempts at addressing this problem and increasing globalization have been demonstrated through medical tourism, which has made progress but also suffered some setbacks.
Publish Date:
International trade has allowed business to grow all around the world and has created an interconnected marketplace for goods and services. However, despite these major benefits, risks have also emerged. Experts estimate that 10 percent of medicinal goods around the world are counterfeit and the sale of counterfeit medicine has risen 90% in the last five years. This phenomenon has been attributed to the increasing amount of merchandise crossing borders and the growing sophistication of counterfeit methods. How has counterfeit medicine affected the global healthcare industry?
Publish Date:
While Liberia was trying to become the next economic superstar in Africa, Ebola came and brought a sharp break in economic growth. The decline in growth is not just happening in Liberia. Across Africa, The Ebola outbreak has brought a series of pessimistic consequences: construction has halted, people have lost jobs, and foreign investors have left. Above all, Ebola has ravaged the health sector and the agriculture industry.
Publish Date:
In the global healthcare industry, glocalization is an emerging trend. Glocalization, a term derived from combining the words globalization and localization, describes the adaptation of global products and services to meet the needs of people in a specific geographic location. Many healthcare industry challenges are shared around the world; however, the effects of these challenges are generally influenced by local issues. A surge in global healthcare spending, along with glocalization, is presenting pharmaceutical companies with both great challenges and opportunities.